Notice2023-20759
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 26, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 185 (Tuesday, September 26, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 185 (Tuesday, September 26, 2023)]
[Notices]
[Pages 66003-66004]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-20759]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1305]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Chronic Q Fever in the United States:
Enhanced Clinical Surveillance'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on June 27, 2023 to obtain comments from the public and affected
agencies. CDC received no comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Chronic Q Fever in the United States: Enhanced Clinical
Surveillance (OMB Control No. 0920-1305, Exp. 9/30/2023)--Revision--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Q fever is a worldwide zoonosis caused by Coxiella burnetii with
acute and chronic disease presentations. Chronic Q fever can manifest
months to years after the primary infection and is rare, occurring in
<5% of persons with an acute infection. Chronic Q fever can take on
several clinical forms, including endocarditis, chronic hepatitis,
chronic vascular infections, osteomyelitis, and osteoarthritis. In the
United States, Q fever cases are reported via the National Notifiable
Disease Surveillance System; however, limited information is collected
on the various clinical manifestations of chronic Q fever or patients
pre-existing risk factors. Data on outcomes other than death or
hospitalizations are not collected by the current surveillance. Because
of this lack of data, the true burden and proportion of cases
exhibiting endocarditis and other forms of chronic Q fever in the
United States is unknown. We plan to establish an enhanced medical
surveillance for chronic Q fever by working with consulting clinicians
to gather additional and more specific clinical data not otherwise
collected during the course of routine public health surveillance for
chronic Q fever. This information will allow for better
characterization of the clinical presentation and risk factors of
chronic Q fever in the United States. The results will help
characterize an under-recognized disease and provide valuable data to
educate physicians on identifying and diagnosing these cases.
Recently, there has been an increased volume of clinical
consultation requests. To reflect this, we are proposing an increase in
the number of respondents to 50 each year. Additionally, the clinical
course for these patients is often complex, and clinical relapse or
prolonged infection has been reported. To capture these important
clinical details, we propose increasing the number of total instruments
to two, with a follow-up survey that will take five minutes each at
six, 12, 18, and 24 months from the date of the initial consult.
CDC requests OMB approval for an estimated 34 annual burden hours.
There is no cost to respondents other than their time to participate.
[[Page 66004]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Physician............................. Chronic Q fever Enhanced 50 1 20/60
Surveillance Report
Form--Initial Consult.
Physician............................. Chronic Q fever Enhanced 50 2 10/60
Surveillance Report
Form--Follow-up.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-20759 Filed 9-25-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on September 26, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.